Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
15
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Lennon David James | CHIEF EXECUTIVE OFFICER, Director | 22 | $0 | $1.06M | 2026-09-15 |
| Dugan Margaret | Chief Medical Officer | 12 | $0 | $0 | 2026-09-15 |
| Dornan David | Chief Scientific Officer | 9 | $0 | $0 | 2026-09-15 |
| BALL BRYAN | See remarks | 21 | $0 | $635.1K | 2026-09-15 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | 19 | $0 | $890.6K | 2026-09-15 |
| Iyengar Vijay K | Director | 2 | $0 | $0 | 2026-09-09 |
| Zhao Baiteng | Director | 2 | $0 | $0 | 2026-06-12 |
| Desai Neil | Director | 2 | $0 | $0 | 2026-06-12 |
| Aghazadeh Behzad | Director, 10% Owner | 1 | $0 | $0 | 2026-06-12 |
| Reeve Emma | Director | 2 | $0 | $0 | 2026-06-12 |
| Hirmand Mohammad | Director | 2 | $0 | $0 | 2026-06-12 |
| Dalal Anupam | Director | 5 | $0 | $0 | 2026-06-12 |
| Maroun Richard E | Director | 2 | $0 | $0 | 2026-06-12 |
| Castelein Caley | Director | 4 | $0 | $0 | 2026-06-12 |
| Avoro Ventures LLC | Director, 10% Owner | 2 | $0 | $0 | 2026-05-12 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| BALL BRYAN | See remarks | A Award deriv | 2026-09-15 | 2026-09-15 | 91,633 | — | $0 | 91,633 | SEC↗ |
| BALL BRYAN | See remarks | A Award deriv | 2026-09-15 | 2026-09-15 | 91,633 | — | $0 | 91,633 | SEC↗ |
| Dornan David | Chief Scientific Officer | A Award deriv | 2026-09-15 | 2026-09-15 | 85,887 | — | $0 | 85,887 | SEC↗ |
| Dornan David | Chief Scientific Officer | A Award deriv | 2026-09-15 | 2026-09-15 | 85,887 | — | $0 | 85,887 | SEC↗ |
| Dugan Margaret | Chief Medical Officer | A Award deriv | 2026-09-15 | 2026-09-15 | 81,250 | — | $0 | 81,250 | SEC↗ |
| Dugan Margaret | Chief Medical Officer | A Award deriv | 2026-09-15 | 2026-09-15 | 81,250 | — | $0 | 81,250 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-09-15 | 2026-09-15 | 118,476 | — | $0 | 118,476 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-09-15 | 2026-09-15 | 118,476 | — | $0 | 118,476 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | A Award deriv | 2026-09-15 | 2026-09-15 | 193,957 | — | $0 | 193,957 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | A Award deriv | 2026-09-15 | 2026-09-15 | 193,957 | — | $0 | 193,957 | SEC↗ |
| Dugan Margaret | Chief Medical Officer | A Award deriv | 2026-09-15 | 2026-09-18 | 81,250 | — | $0 | 81,250 | SEC↗ |
| Dugan Margaret | Chief Medical Officer | A Award deriv | 2026-09-15 | 2026-09-18 | 81,250 | — | $0 | 81,250 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | A Award deriv | 2026-09-15 | 2026-09-18 | 193,957 | — | $0 | 193,957 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | A Award deriv | 2026-09-15 | 2026-09-18 | 193,957 | — | $0 | 193,957 | SEC↗ |
| Dornan David | Chief Scientific Officer | A Award deriv | 2026-09-15 | 2026-09-18 | 85,887 | — | $0 | 85,887 | SEC↗ |
| Dornan David | Chief Scientific Officer | A Award deriv | 2026-09-15 | 2026-09-18 | 85,887 | — | $0 | 85,887 | SEC↗ |
| BALL BRYAN | See remarks | A Award deriv | 2026-09-15 | 2026-09-18 | 91,633 | — | $0 | 91,633 | SEC↗ |
| BALL BRYAN | See remarks | A Award deriv | 2026-09-15 | 2026-09-18 | 91,633 | — | $0 | 91,633 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-09-15 | 2026-09-18 | 118,476 | — | $0 | 118,476 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-09-15 | 2026-09-18 | 118,476 | — | $0 | 118,476 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER, Dir | A Award deriv | 2026-09-15 | 2026-09-15 | 193,957 | — | $0 | 193,957 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER, Dir | A Award deriv | 2026-09-15 | 2026-09-15 | 193,957 | — | $0 | 193,957 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-09-15 | 2026-09-15 | 118,476 | — | $0 | 118,476 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-09-15 | 2026-09-15 | 118,476 | — | $0 | 118,476 | SEC↗ |
| Dugan Margaret | Chief Medical Officer | A Award deriv | 2026-09-15 | 2026-09-15 | 81,250 | — | $0 | 81,250 | SEC↗ |
| Dugan Margaret | Chief Medical Officer | A Award deriv | 2026-09-15 | 2026-09-15 | 81,250 | — | $0 | 81,250 | SEC↗ |
| Dornan David | Chief Scientific Officer | A Award deriv | 2026-09-15 | 2026-09-15 | 85,887 | — | $0 | 85,887 | SEC↗ |
| Dornan David | Chief Scientific Officer | A Award deriv | 2026-09-15 | 2026-09-15 | 85,887 | — | $0 | 85,887 | SEC↗ |
| BALL BRYAN | See remarks | A Award deriv | 2026-09-15 | 2026-09-15 | 91,633 | — | $0 | 91,633 | SEC↗ |
| BALL BRYAN | See remarks | A Award deriv | 2026-09-15 | 2026-09-15 | 91,633 | — | $0 | 91,633 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER, Dir | A Award deriv | 2026-09-15 | 2026-09-18 | 193,957 | — | $0 | 193,957 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER, Dir | A Award deriv | 2026-09-15 | 2026-09-18 | 193,957 | — | $0 | 193,957 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-09-15 | 2026-09-18 | 118,476 | — | $0 | 118,476 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-09-15 | 2026-09-18 | 118,476 | — | $0 | 118,476 | SEC↗ |
| Dugan Margaret | Chief Medical Officer | A Award deriv | 2026-09-15 | 2026-09-18 | 81,250 | — | $0 | 81,250 | SEC↗ |
| Dugan Margaret | Chief Medical Officer | A Award deriv | 2026-09-15 | 2026-09-18 | 81,250 | — | $0 | 81,250 | SEC↗ |
| Dornan David | Chief Scientific Officer | A Award deriv | 2026-09-15 | 2026-09-18 | 85,887 | — | $0 | 85,887 | SEC↗ |
| Dornan David | Chief Scientific Officer | A Award deriv | 2026-09-15 | 2026-09-18 | 85,887 | — | $0 | 85,887 | SEC↗ |
| BALL BRYAN | See remarks | A Award deriv | 2026-09-15 | 2026-09-18 | 91,633 | — | $0 | 91,633 | SEC↗ |
| BALL BRYAN | See remarks | A Award deriv | 2026-09-15 | 2026-09-18 | 91,633 | — | $0 | 91,633 | SEC↗ |
| Iyengar Vijay K | Director | A Award deriv | 2026-09-09 | 2026-09-11 | 76,080 | — | $0 | 76,080 | SEC↗ |
| Iyengar Vijay K | Director | A Award deriv | 2026-09-09 | 2026-09-11 | 76,080 | — | $0 | 76,080 | SEC↗ |
| Dalal Anupam | Director | A Award deriv | 2026-06-12 | 2026-07-30 | 38,040 | — | $0 | 38,040 | SEC↗ |
| Aghazadeh Behzad | Director, 10% Owner | A Award deriv | 2026-06-12 | 2026-06-15 | 38,040 | — | $0 | 38,040 | SEC↗ |
| Castelein Caley | Director | A Award deriv | 2026-06-12 | 2026-06-15 | 38,040 | — | $0 | 38,040 | SEC↗ |
| Desai Neil | Director | A Award deriv | 2026-06-12 | 2026-06-15 | 38,040 | — | $0 | 38,040 | SEC↗ |
| Hirmand Mohammad | Director | A Award deriv | 2026-06-12 | 2026-06-15 | 38,040 | — | $0 | 38,040 | SEC↗ |
| Maroun Richard E | Director | A Award deriv | 2026-06-12 | 2026-06-15 | 38,040 | — | $0 | 38,040 | SEC↗ |
| Reeve Emma | Director | A Award deriv | 2026-06-12 | 2026-06-15 | 38,040 | — | $0 | 38,040 | SEC↗ |
| Zhao Baiteng | Director | A Award deriv | 2026-06-12 | 2026-06-15 | 38,040 | — | $0 | 38,040 | SEC↗ |
| Dalal Anupam | Director | A Award deriv | 2026-06-12 | 2026-07-30 | 38,040 | — | $0 | 38,040 | SEC↗ |
| Dalal Anupam | Director | A Award | 2026-05-14 | 2026-07-30 | 1,275,510 | $3.92 | $5.00M | 4,685,912 | SEC↗ |
| Castelein Caley | Director | A Award deriv | 2026-05-14 | 2026-05-18 | 2,072,756 | $8124996.24 | $16841.13B | 2,072,756 | SEC↗ |
| Castelein Caley | Director | A Award | 2026-05-14 | 2026-05-18 | 255,102 | $3.92 | $1000.0K | 274,796 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | A Award | 2026-05-14 | 2026-05-18 | 51,021 | $3.92 | $200.0K | 569,643 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award | 2026-05-14 | 2026-05-18 | 38,265 | $3.92 | $150.0K | 333,489 | SEC↗ |
| BALL BRYAN | See remarks | A Award | 2026-05-14 | 2026-05-18 | 51,020 | $3.92 | $200.0K | 448,126 | SEC↗ |
| Dugan Margaret | Chief Medical Officer | A Award | 2026-05-14 | 2026-05-18 | 19,132 | $3.92 | $75.0K | 19,132 | SEC↗ |
| Dalal Anupam | Director | A Award | 2026-05-14 | 2026-07-30 | 1,275,510 | $3.92 | $5.00M | 4,685,912 | SEC↗ |
| Avoro Ventures LLC | Director, 10% Owner | A Award deriv | 2026-05-12 | 2026-05-14 | 6,377,714 | $3.92 | $25.00M | 14,710,714 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | S Sale | 2026-04-16 | 2026-04-17 | 141,600 | $4.13 | $584.8K | 295,224 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | S Sale | 2026-04-15 | 2026-04-17 | 77,000 | $3.86 | $297.2K | 436,824 | SEC↗ |
| BALL BRYAN | See remarks | S Sale | 2026-04-14 | 2026-04-15 | 92,460 | $3.64 | $336.6K | 397,106 | SEC↗ |
| BALL BRYAN | See remarks | S Sale | 2026-04-13 | 2026-04-15 | 26,389 | $3.46 | $91.3K | 489,566 | SEC↗ |
| BALL BRYAN | See remarks | S Sale | 2026-04-10 | 2026-04-13 | 6,596 | $3.43 | $22.6K | 515,955 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | S Sale | 2026-04-09 | 2026-04-10 | 14,500 | $3.38 | $49.0K | 518,622 | SEC↗ |
| BALL BRYAN | See remarks | S Sale | 2026-04-09 | 2026-04-13 | 50,000 | $3.57 | $178.5K | 522,551 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | S Sale | 2026-04-08 | 2026-04-08 | 63,945 | $3.40 | $217.4K | 533,122 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | S Sale | 2026-04-07 | 2026-04-08 | 94,087 | $3.43 | $322.7K | 597,067 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | S Sale | 2026-04-06 | 2026-04-08 | 102,395 | $3.51 | $359.4K | 691,154 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | S Sale | 2026-04-02 | 2026-04-03 | 26,858 | $3.48 | $93.5K | 793,549 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 831,148 | — | $0 | 831,148 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 775,828 | — | $0 | 0 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award deriv | 2026-04-01 | 2026-04-03 | 300,677 | — | $0 | 300,677 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-04-01 | 2026-04-03 | 473,902 | — | $0 | 0 | SEC↗ |
| BALL BRYAN | See remarks | A Award deriv | 2026-04-01 | 2026-04-03 | 250,058 | — | $0 | 250,058 | SEC↗ |
| BALL BRYAN | See remarks | M Exercise deriv | 2026-04-01 | 2026-04-03 | 366,532 | — | $0 | 0 | SEC↗ |
| Dugan Margaret | Chief Medical Officer | A Award deriv | 2026-04-01 | 2026-04-03 | 283,157 | — | $0 | 283,157 | SEC↗ |
| Dornan David | Chief Scientific Officer | A Award deriv | 2026-04-01 | 2026-04-03 | 282,340 | — | $0 | 282,340 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | M Exercise | 2026-04-01 | 2026-04-03 | 775,828 | — | $0 | 820,407 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M Exercise | 2026-04-01 | 2026-04-03 | 473,902 | — | $0 | 502,002 | SEC↗ |
| BALL BRYAN | See remarks | M Exercise | 2026-04-01 | 2026-04-03 | 366,532 | — | $0 | 572,551 | SEC↗ |
| BALL BRYAN | See remarks | S Sale | 2026-03-02 | 2026-03-10 | 1,834 | $3.31 | $6.1K | 206,019 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | S Sale | 2026-03-02 | 2026-03-10 | 2,594 | $3.31 | $8.6K | 28,100 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | S Sale | 2026-03-02 | 2026-03-10 | 5,100 | $3.31 | $16.9K | 44,579 | SEC↗ |
| BALL BRYAN | See remarks | M Exercise deriv | 2026-03-01 | 2026-03-10 | 5,000 | — | $0 | 10,000 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2026-03-01 | 2026-03-10 | 6,750 | — | $0 | 13,500 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2026-03-01 | 2026-03-10 | 16,250 | — | $0 | 32,500 | SEC↗ |
| BALL BRYAN | See remarks | M Exercise | 2026-03-01 | 2026-03-10 | 5,000 | — | $0 | 207,853 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M Exercise | 2026-03-01 | 2026-03-10 | 6,750 | — | $0 | 30,694 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | M Exercise | 2026-03-01 | 2026-03-10 | 16,250 | — | $0 | 49,679 | SEC↗ |
| Dugan Margaret | Chief Medical Officer | A Award deriv | 2025-12-01 | 2025-12-02 | 650,000 | — | $0 | 650,000 | SEC↗ |
| Dugan Margaret | Chief Medical Officer | A Award deriv | 2025-12-01 | 2025-12-02 | 55,309 | — | $0 | 55,309 | SEC↗ |
| Zhao Baiteng | Director | A Award deriv | 2025-06-17 | 2025-06-17 | 40,006 | — | $0 | 40,006 | SEC↗ |
| Avoro Ventures LLC | Director, 10% Owner | A Award deriv | 2025-06-12 | 2025-06-16 | 40,006 | — | $0 | 40,006 | SEC↗ |
| Dalal Anupam | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 40,006 | — | $0 | 40,006 | SEC↗ |
| Castelein Caley | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 40,006 | — | $0 | 40,006 | SEC↗ |
| Reeve Emma | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 40,006 | — | $0 | 40,006 | SEC↗ |
| Maroun Richard E | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 40,006 | — | $0 | 40,006 | SEC↗ |
| Hirmand Mohammad | Director | A Award deriv | 2025-06-12 | 2025-06-16 | 40,006 | — | $0 | 40,006 | SEC↗ |
| Desai Neil | Director | A Award deriv | 2025-06-12 | 2025-06-17 | 40,006 | — | $0 | 40,006 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-04-01 | 2025-04-03 | 775,828 | — | $0 | 775,828 | SEC↗ |
| Lennon David James | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-04-01 | 2025-04-03 | 775,828 | — | $0 | 775,828 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award deriv | 2025-04-01 | 2025-04-03 | 473,902 | — | $0 | 473,902 | SEC↗ |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A Award deriv | 2025-04-01 | 2025-04-03 | 473,902 | — | $0 | 473,902 | SEC↗ |
| BALL BRYAN | See remarks | A Award deriv | 2025-04-01 | 2025-04-03 | 366,532 | — | $0 | 366,532 | SEC↗ |
| BALL BRYAN | See remarks | A Award deriv | 2025-04-01 | 2025-04-03 | 366,532 | — | $0 | 366,532 | SEC↗ |